Recent technological and legal developments have increased the need for pharma and biotech companies to integrate clear data and trade secrets strategies into their broader IP approach.
Recent technological and legal developments have increased the need for pharma and biotech companies to integrate clear data and trade secrets strategies into their broader IP approach.